标题
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
作者
关键词
Heterogeneity, Low-grade cancer, Ovarian serous carcinoma, Mutation, KRAS, BRAF, NRAS, SMAD4
出版物
BMC CANCER
Volume 14, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-06-18
DOI
10.1186/1471-2407-14-982
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- BRAF Mutation Is Associated With a Specific Cell Type With Features Suggestive of Senescence in Ovarian Serous Borderline (Atypical Proliferative) Tumors
- (2014) Felix Zeppernick et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The DNA Methylomes of Serous Borderline Tumors Reveal Subgroups With Malignant- or Benign-Like Profiles
- (2013) Constanze Zeller et al. AMERICAN JOURNAL OF PATHOLOGY
- KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants
- (2013) Sabine Heublein et al. BMC CANCER
- Low-grade serous carcinoma: New concepts and emerging therapies
- (2013) Ignacio Romero et al. GYNECOLOGIC ONCOLOGY
- Correlation of Smad4 Status With Outcomes in Patients Receiving Erlotinib Combined With Adjuvant Chemoradiation and Chemotherapy After Resection for Pancreatic Adenocarcinoma
- (2013) Joseph M. Herman et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- KRAS(but notBRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma
- (2013) Yvonne T Tsang et al. JOURNAL OF PATHOLOGY
- Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
- (2013) Ali Bashashati et al. JOURNAL OF PATHOLOGY
- Mutational analysis ofBRAFandKRASin ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants
- (2013) Laura Ardighieri et al. JOURNAL OF PATHOLOGY
- Survival in Women With Grade 1 Serous Ovarian Carcinoma
- (2013) Amanda Nickles Fader et al. OBSTETRICS AND GYNECOLOGY
- BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
- (2012) Rachel N. Grisham et al. CANCER
- Ovarian low-grade serous carcinoma: A comprehensive update
- (2012) Ivan Diaz-Padilla et al. GYNECOLOGIC ONCOLOGY
- Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression
- (2012) Mamadou Keita et al. GYNECOLOGIC ONCOLOGY
- Delineation of the infrequent mosaicism ofKRASmutational status in metastatic colorectal adenocarcinomas
- (2012) Céline Bossard et al. JOURNAL OF CLINICAL PATHOLOGY
- Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
- (2012) John Farley et al. LANCET ONCOLOGY
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Feature-based classifiers for somatic mutation detection in tumour–normal paired sequencing data
- (2011) Jiarui Ding et al. BIOINFORMATICS
- Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole – of clinical importance?
- (2011) J Geisler BRITISH JOURNAL OF CANCER
- Reclassification of serous ovarian carcinoma by a 2-tier system
- (2011) Diane C. Bodurka et al. CANCER
- Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
- (2011) Davide Torti et al. EMBO Molecular Medicine
- Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas
- (2011) Melissa K McConechy et al. JOURNAL OF PATHOLOGY
- Low-grade serous carcinomas of the ovary contain very few point mutations
- (2011) Siân Jones et al. JOURNAL OF PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- An integrated semiconductor device enabling non-optical genome sequencing
- (2011) Jonathan M. Rothberg et al. NATURE
- Predicting the functional impact of protein mutations: application to cancer genomics
- (2011) Boris Reva et al. NUCLEIC ACIDS RESEARCH
- BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas
- (2010) Kwong-Kwok Wong et al. AMERICAN JOURNAL OF PATHOLOGY
- Fast and accurate long-read alignment with Burrows–Wheeler transform
- (2010) Heng Li et al. BIOINFORMATICS
- SMAD4 - Molecular gladiator of the TGF-β signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: an analysis with relation to KRASproto-oncogene
- (2010) A Syed Sameer et al. BMC CANCER
- Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer
- (2010) M. Janakiraman et al. CANCER RESEARCH
- Secondary mutations of BRCA1/2 and drug resistance
- (2010) Kiranjit K. Dhillon et al. CANCER SCIENCE
- KRAS and BRAF: drug targets and predictive biomarkers
- (2010) Efsevia Vakiani et al. JOURNAL OF PATHOLOGY
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- Ovarian Low-grade and High-grade Serous Carcinoma
- (2009) Russell Vang et al. ADVANCES IN ANATOMIC PATHOLOGY
- KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
- (2009) F Loupakis et al. BRITISH JOURNAL OF CANCER
- Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice
- (2009) Nathalie Dhomen et al. CANCER CELL
- Analysis of DNA Copy Number Alterations in Ovarian Serous Tumors Identifies New Molecular Genetic Changes in Low-Grade and High-Grade Carcinomas
- (2009) K.-T. Kuo et al. CANCER RESEARCH
- Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
- (2009) David M. Gershenson et al. GYNECOLOGIC ONCOLOGY
- Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
- (2009) Sohrab P. Shah et al. NATURE
- KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer
- (2008) N Nakayama et al. BRITISH JOURNAL OF CANCER
- Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7
- (2008) Narendra Wajapeyee et al. CELL
- Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum
- (2008) Kathleen M. Schmeler et al. GYNECOLOGIC ONCOLOGY
- Molecular Characteristics of Bronchioloalveolar Carcinoma and Adenocarcinoma, Bronchioloalveolar Carcinoma Subtype, Predict Response to Erlotinib
- (2008) Vincent A. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Role ofKRASandEGFRAs Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21
- (2008) Chang-Qi Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Low-grade serous ovarian cancer: a unique disease
- (2008) Kathleen M. Schmeler et al. Current Oncology Reports
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search